See more : Capricorn Energy PLC (CNE.L) Income Statement Analysis – Financial Results
Complete financial analysis of Outset Medical, Inc. (OM) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Outset Medical, Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
You may be interested
- TACHI-S Co., Ltd. (TCISF) Income Statement Analysis – Financial Results
- Nostra Terra Oil and Gas Company plc (NTOG.L) Income Statement Analysis – Financial Results
- Cortelco Systems Puerto Rico, Inc. (CPROF) Income Statement Analysis – Financial Results
- Formosa International Hotels Corporation (2707.TW) Income Statement Analysis – Financial Results
- Cosmo First Limited (COSMOFIRST.NS) Income Statement Analysis – Financial Results
Outset Medical, Inc. (OM)
About Outset Medical, Inc.
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 130.38M | 115.38M | 102.60M | 49.94M | 15.08M | 2.01M |
| Cost of Revenue | 101.38M | 97.54M | 94.99M | 62.97M | 32.88M | 8.12M |
| Gross Profit | 29.00M | 17.83M | 7.61M | -13.04M | -17.80M | -6.12M |
| Gross Profit Ratio | 22.24% | 15.46% | 7.42% | -26.11% | -118.07% | -304.68% |
| Research & Development | 57.31M | 48.86M | 36.74M | 28.85M | 23.33M | 22.92M |
| General & Administrative | 45.23M | 40.52M | 36.32M | 30.51M | 8.92M | 6.25M |
| Selling & Marketing | 96.23M | 89.48M | 65.07M | 45.07M | 20.26M | 11.28M |
| SG&A | 141.46M | 130.00M | 101.39M | 75.58M | 29.18M | 17.53M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 198.77M | 178.85M | 138.13M | 104.43M | 52.51M | 40.45M |
| Cost & Expenses | 300.15M | 276.39M | 233.12M | 167.40M | 85.39M | 48.57M |
| Interest Income | 10.17M | 3.29M | 498.00K | 526.00K | 2.49M | 1.71M |
| Interest Expense | 12.68M | 3.57M | 1.72M | 2.37M | 4.26M | 4.64M |
| Depreciation & Amortization | 5.81M | 6.28M | 6.18M | 3.76M | 1.94M | 1.49M |
| EBITDA | -153.79M | -152.81M | -124.86M | -114.85M | -62.09M | -43.62M |
| EBITDA Ratio | -117.96% | -136.71% | -126.72% | -235.24% | -436.97% | -2,181.61% |
| Operating Income | -169.77M | -161.02M | -130.52M | -117.47M | -70.31M | -46.56M |
| Operating Income Ratio | -130.22% | -139.56% | -127.21% | -235.24% | -466.29% | -2,320.03% |
| Total Other Income/Expenses | -2.50M | -1.64M | -1.22M | -4.03M | 2.03M | -3.19M |
| Income Before Tax | -172.27M | -162.66M | -131.74M | -121.49M | -68.28M | -49.76M |
| Income Before Tax Ratio | -132.14% | -140.98% | -128.40% | -243.30% | -452.84% | -2,479.07% |
| Income Tax Expense | 523.00K | 295.00K | 199.00K | -794.00K | 20.00K | 25.00K |
| Net Income | -172.80M | -162.96M | -131.94M | -120.70M | -68.30M | -49.78M |
| Net Income Ratio | -132.54% | -141.24% | -128.59% | -241.71% | -452.97% | -2,480.32% |
| EPS | -3.48 | -3.38 | -2.89 | -2.83 | -1.61 | -1.65 |
| EPS Diluted | -3.48 | -3.38 | -2.89 | -2.83 | -1.61 | -1.65 |
| Weighted Avg Shares Out | 49.59M | 48.16M | 45.59M | 42.72M | 42.33M | 30.08M |
| Weighted Avg Shares Out (Dil) | 49.59M | 48.16M | 45.59M | 42.72M | 42.33M | 30.08M |
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Outset Medical, Inc. - OM
NEW YORK, NY / ACCESSWIRE / October 27, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Outset Medical, Inc. ("Outset Medical" or the "Company") (NASDAQ:OM). Such investors are advised to contact Danielle Peyton at...
FINAL REMINDER OM DEADLINE: Bronstein, Gewirtz & Grossman LLC Alerts Outset Medical, Inc. Investors to Participate in the Class Action Lawsuit!
NEW YORK CITY, NY / ACCESSWIRE / October 27, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Outset Medical, Inc. ("Outset Medical" or "the Company")...
OM DEADLINE: ROSEN, A RANKED AND LEADING FIRM, Encourages Outset Medical, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important October 28 Deadline in Securities Class Action – OM
NEW YORK, Oct. 25, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Outset Medical, Inc. (NASDAQ: OM) between September 15, 2020 and August 7, 2024, both dates inclusive (the...
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Outset Medical, Inc. - OM
NEW YORK , Oct. 25, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Outset Medical, Inc. ("Outset Medical" or the "Company") (NASDAQ: OM). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or...
OM Investors Have Opportunity to Lead Outset Medical, Inc. Securities Fraud Lawsuit
LOS ANGELES , Oct. 25, 2024 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Outset Medical, Inc. ("Outset Medical" or the "Company") (NASDAQ:...
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Outset Medical, Inc. (OM)
LOS ANGELES, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming October 28, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or...
Outset Medical, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. Oct. 28, 2024 Deadline to file Lead Plaintiff Motion
Investors can contact the law firm at no cost to learn more about recovering their losses
New Research Highlights Improvements in Quality of Life and Caregiver Experience for Home Hemodialysis Patients Using Tablo
Outset Medical features patient experience poster presentations at Kidney Week 2024
OM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Outset Medical, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NEW YORK, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Outset Medical, Inc. (“Outset Medical” or “the Company”)...
OM LAWSUIT ALERT: Levi & Korsinsky Notifies Outset Medical, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, NY / ACCESSWIRE / October 23, 2024 / If you suffered a loss on your Outset Medical, Inc. (NASDAQ:OM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for...
Source: https://incomestatements.info
Category: Stock Reports